Pieris Pharmaceuticals, Inc. General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Note 5 - Accrued Expenses and Other Current Liabilities 2 (Tables)

Note 5 - Accrued Expenses and Other Current Liabilities 2 (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2024

Dec. 31, 2023

Notes Tables

Schedule of Accrued Expenses and Other Current Liabilities [Table Text Block]

		September 30,				December 31,
		2024				2023
Professional fees		$	2,343			$	960
Compensation expense			1,462				175
Research and development expenses			418				120
Other			282				169
Total accrued expenses and other current liabilities		$	4,505			$	1,424

		December 31,
		2023				2022
Professional fees		$	960			$	997
Compensation expense			175				762
Research and development expenses			120				683
Other			169				159
Total accrued expenses and other current liabilities		$	1,424			$	2,601